This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

CVS/pharmacy Partners With The American Diabetes Association To Sponsor "A Day In The Life Of Diabetes" For National Diabetes Month

Stocks in this article: CVS









WOONSOCKET, R.I., Nov. 1, 2012 /PRNewswire/ -- CVS/pharmacy ® is partnering with the American Diabetes Association (ADA) as the sponsor of "A Day in the Life of Diabetes" campaign – a photo sharing campaign on the ADA's main Facebook page. The CVS/pharmacy ExtraCare Advantage for Diabetes ® program will donate $1 to the American Diabetes Association for every photo or image uploaded, up to $25,000. CVS/pharmacy will also co-host a Twitter Chat on November 15 with Dr. Elizabeth Seaquist, Vice President of Medicine & Science for the ADA.

(Logo: http://photos.prnewswire.com/prnh/20100816/NE50800LOGO )

"With 26 million people afflicted with the disease in the U.S. and an additional 79 million Americans at risk for type 2 diabetes, this chronic condition has reached epic proportions," said Papatya Tankut, RPh, Vice President of Pharmacy Affairs, CVS Caremark. "By working together with the American Diabetes Association, we're able to cast a wider net to help more people on their path to better health by sharing educational resources and spreading awareness of programs that can help them to manage diabetes and save money."

Additional activities happening during American Diabetes Month include:

  • Twitter Chat: To help educate CVS/pharmacy customers about diabetes and how to care for those with diabetes, CVS/pharmacy and the American Diabetes Association will co-host a live Twitter chat on the @CVS_Extra handle, featuring a CVS pharmacist and Dr. Elizabeth Seaquist, Vice President of Medicine & Science for the ADA via the @AmDiabetesAssn handle. The Twitter chat will take place on Thursday, November 15, from 3-4 p.m. EST. Users that participate in the chat by using the #diabetesmonth or #CVSECAD hashtag, will automatically be entered to win prize packs from the CVS/pharmacy ExtraCare Advantage for Diabetes program.
  • ExtraCare Advantage for Diabetes Member Drive: The program is free and open to all members of the CVS/pharmacy ExtraCare savings and rewards program; cardholders can easily sign up at CVS.com/diabetes. Once enrolled, patients and caregivers gain access to:
    • $5 coupon for joining
    • Monthly e-newsletter filled with recipes, tips and extra savings
    • More than $130 in savings from Diabetes Health Magazine available through December 31, 2012.

ExtraCare Advantage for Diabetes members earn ExtraBucks ® Rewards on more than 100 products used to manage diabetes, including testing supplies, glucose test strips and glucose meters. In addition to exclusive savings, members also have access to a variety of resources including an "Ask Our Pharmacist" section, additional offers, videos and recipes addressing their specific lifestyle needs. Members can log on to CVS.com/extracare or access the CVS mobile app to view the personalized ExtraSavings™ and ExtraBucks Rewards that are currently available, and choose to "Print" or "Send to Card" their coupon savings and ExtraBucks   Rewards. 

In addition to earning ExtraBucks Rewards that can be spent on most items in the store, ExtraCare Advantage for Diabetes members receive special offers and discounts on their receipts and at the in-store ExtraCare Coupon Center. Members can visit the Information & Advice center on CVS.com, which features videos and answers from the pharmacist year round.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs